MetLife Investment Management’s Celanese CE Stock Holding History

MetLife Investment Management’s Portfolio CE Stock Details CE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$118K	Buy	1,792 +3	+0.2%	+$157	﹤0.01%	2466
2025 Q4	$75.6K	Sell	1,789 -71	-4%	-$2.9K	﹤0.01%	2682
2025 Q3	$78.3K	Buy	1,860 +2	+0.1%	+$100	﹤0.01%	2738
2025 Q2	$103K	Sell	1,858 -1,313	-41%	-$65.4K	﹤0.01%	2527
2025 Q1	$180K	Sell	3,171 -26,978	-89%	-$1.68M	﹤0.01%	2259
2024 Q4	$2.09M	Buy	30,149 +479	+2%	+$46K	0.01%	1011
2024 Q3	$4.03M	Buy	29,670 +1,361	+5%	+$179K	0.02%	653
2024 Q2	$3.82M	Buy	28,309 +4,889	+21%	+$747K	0.02%	641
2024 Q1	$4.02M	Sell	23,420 -862	-4%	-$131K	0.03%	615
2023 Q4	$3.77M	Sell	24,282 -445	-2%	-$58K	0.03%	637
2023 Q3	$3.1M	Sell	24,727 -647	-3%	-$79.5K	0.02%	691
2023 Q2	$2.94M	Sell	25,374 -543	-2%	-$58.8K	0.02%	760
2023 Q1	$2.82M	Sell	25,917 -308	-1%	-$35.6K	0.02%	771
2022 Q4	$2.68M	Sell	26,225 -408	-2%	-$40.5K	0.02%	775
2022 Q3	$2.41M	Sell	26,633 -2,542	-9%	-$279K	0.02%	798
2022 Q2	$3.43M	Sell	29,175 -2,007	-6%	-$288K	0.03%	650
2022 Q1	$4.45M	Buy	31,182 +7,129	+30%	+$1.09M	0.03%	611
2021 Q4	$4.04M	Sell	24,053 -1,042	-4%	-$170K	0.03%	508
2021 Q3	$3.78M	Sell	25,095 -1,017	-4%	-$157K	0.03%	511
2021 Q2	$3.96M	Sell	26,112 -1,095	-4%	-$174K	0.03%	516
2021 Q1	$4.08M	Sell	27,207 -1,181	-4%	-$162K	0.04%	497
2020 Q4	$3.69M	Sell	28,388 -1,604	-5%	-$199K	0.03%	516
2020 Q3	$3.22M	Sell	29,992 -928	-3%	-$92.6K	0.04%	504
2020 Q2	$2.67M	Sell	30,920 -236	-0.8%	-$19.7K	0.03%	583
2020 Q1	$2.29M	Sell	31,156 -954	-3%	-$94.4K	0.03%	554
2019 Q4	$3.95M	Sell	32,110 -1,564	-5%	-$192K	0.04%	470
2019 Q3	$4.12M	Sell	33,674 -1,225	-4%	-$138K	0.05%	419
2019 Q2	$3.76M	Sell	34,899 -1,515	-4%	-$157K	0.04%	494
2019 Q1	$3.59M	Sell	36,414 -1,838	-5%	-$181K	0.04%	516
2018 Q4	$3.44M	Buy	38,252 +38,065	+20,356%	+$3.73M	0.04%	452
2018 Q3	$21.3K	Buy	+187	New	+$21.4K	﹤0.01%	2380

Other funds holding CE

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

TCAM

Turtle Creek Asset Management Toronto, Ontario, Canada $2.67B AUM 0.64% 1-Year Est. Return

MetLife Investment Management's CE Position: Q1 2026 in Review

MetLife Investment Management increased its Celanese (CE) stake by 0.17% in Q1 2026, buying an estimated $157 and bringing the position to 1,792 shares worth $118K. The position accounts for ﹤0.01% of the portfolio, ranked #2466.

MetLife Investment Management first reported a position in CE in Q3 2018 and has held it in 31 quarters since. The position peaked at $4.45M in Q1 2022. 471 funds tracked by Wall St. Rank hold CE as of Q1 2026.

MetLife Investment Management held 1,792 shares of Celanese worth $118K as of Q1 2026.
MetLife Investment Management bought 3 Celanese shares in Q1 2026, an estimated $157.
Celanese made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2466 holding.
MetLife Investment Management first reported a position in Celanese in Q3 2018 and has held it in 31 quarters since.
MetLife Investment Management's Celanese position peaked at $4.45M in Q1 2022.
471 funds tracked by Wall St. Rank held Celanese as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.